PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Media

Media

Welcome to BioMarin's Online Press Room.

We've brought together a variety of information in one location to better assist you in your efforts to research and develop news articles. Should you require additional information, please call or e-mail us any time.

Contact Information:
415-455-7451
corporatecommunications2@BMRN.com

Recent News

  • BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Brazil for Treatment of Morquio A Syndrome...  MORE >
  • FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of MPS IIIB (Sanfilippo Syndrome Type B)...  MORE >
  • BioMarin to Highlight Breadth of Innovative Development Pipeline at Analyst and Investor Day on December 10th in New York...  MORE >